Zhou S, Long N, Rosenke K, Jarvis MA, et al. Combined Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 Reduces Molnupiravir-Induced Mutagenicity and Prevents Selection for Nirmatrelvir/Ritonavir Resistance Mutations. J Infect Dis 2024 Jul 8:jiae213. doi: 10.1093.
PMID: 38973065